Showing 1 - 10 of 54
ABSTRACT This paper describes the development of a methodology for the case‐mix adjustment of patient‐reported outcome measures (PROMs) data permitting the comparison of outcomes between providers on a like‐for‐like basis. Statistical models that take account of provider‐specific...
Persistent link: https://www.econbiz.de/10011160893
Persistent link: https://www.econbiz.de/10011005457
Persistent link: https://www.econbiz.de/10010144918
HASH(0x1009b7638)
Persistent link: https://www.econbiz.de/10008455467
Objectives The UK's National Institute of Health and Clinical Excellence (NICE) has an explicit cost-effectiveness threshold for deciding whether or not services are to be provided in the National Health Service (NHS), but there is currently little evidence to support the level at which it is...
Persistent link: https://www.econbiz.de/10005077662
Accounting for variation in the quality of care is a major challenge for the assessment of hospital cost performance. Because data on patients’ health improvement are generally not available, existing studies have resorted to inherently incomplete outcome measures such as mortality or...
Persistent link: https://www.econbiz.de/10010533834
This paper critically reviews theoretical and empirical propositions regarding visual analogue scale (VAS) valuations of health states and their use in cost-utility analysis (CUA). A widely repeated assertion in the economic evaluation literature is the inferiority, on theoretical grounds, of...
Persistent link: https://www.econbiz.de/10005440519
The decisions made by the National Institute for Clinical Excellence (NICE) give rise to two questions: how is cost-effectiveness evidence used to make judgements about the 'value for money' of health technologies? And how are factors other than cost-effectiveness taken into account? The aim of...
Persistent link: https://www.econbiz.de/10005440585
Persistent link: https://www.econbiz.de/10005442759
Persistent link: https://www.econbiz.de/10005547406